Latvia ZVA (State Agency of Medicines) · March 08, 2026

Supply notice: discontinuation of Protaphane FlexPen and Levemir

Original title: Paziņojums par zāļu piegādes pārtraukumu: “Atsevišķu zāļu tirdzniecības apturēšana (pārtraukšana): Protaphane FlexPen, Levemir”

Novo Nordisk Latvia announces discontinuation of Protaphane FlexPen and Levemir insulin products.

Low obligation Product class Pharmaceuticals Latvia Supply shortages

03.08.2026. Novo Nordisk Latvia SIA informācija veselības aprūpes speciālistam par Levemir un Protaphane FlexPen ir pieejama šeit. Tiecamauditorija. Lasīt tālāk Facebook Twitter Google

Dates and deadlines

Applies from

2026-08-03

Read the official source ↗

Published by Latvia ZVA (State Agency of Medicines). HealthSignal links to the original document; the summary above is extracted from the source text.